Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Renal Transplantation”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Large-scale testing (Phase 3)Study completedNCT00478608
What this trial is testing

Study Evaluating Rapamune® Maintenance Regimen

Who this might be right for
Renal Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 79
Testing effectiveness (Phase 2)Study completedNCT01320358
What this trial is testing

Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients

Who this might be right for
Detection AccuracyPatient Compliance
Novartis Pharmaceuticals 30
Post-approval studies (Phase 4)Looking for participantsNCT06751992
What this trial is testing

Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

Who this might be right for
Kidney Transplant RecipientsOld Age
Massachusetts General Hospital 92
Post-approval studies (Phase 4)Ended earlyNCT00177138
What this trial is testing

Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation

Who this might be right for
Diabetes Mellitus
University of Minnesota 9
Testing effectiveness (Phase 2)Study completedNCT00309270
What this trial is testing

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Who this might be right for
Kidney Transplant
Mario Negri Institute for Pharmacological Research 21
Post-approval studies (Phase 4)Study completedNCT00905242
What this trial is testing

Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients

Who this might be right for
Kidney Transplantation
East Carolina University 61
Post-approval studies (Phase 4)Study completedNCT00400647
What this trial is testing

Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil

Who this might be right for
Maintenance Kidney Transplant
Novartis 136
Large-scale testing (Phase 3)Study completedNCT00425308
What this trial is testing

Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 30
Post-approval studies (Phase 4)Study completedNCT00241059
What this trial is testing

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 183
Large-scale testing (Phase 3)Study completedNCT00461825
What this trial is testing

Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation

Who this might be right for
Kidney Transplantation
Poitiers University Hospital 207
Post-approval studies (Phase 4)Study completedNCT01044303
What this trial is testing

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Who this might be right for
Transplant; Failure, Kidney
East Carolina University 32
Not applicableUnknownNCT02091973
What this trial is testing

MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation

Who this might be right for
microRNA Profiles
Chulalongkorn University 50
Large-scale testing (Phase 3)WithdrawnNCT04420364
What this trial is testing

Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease

Who this might be right for
COVIDKidney Transplant; ComplicationsImmunosuppression
Brigham and Women's Hospital
Large-scale testing (Phase 3)Study completedNCT01476488
What this trial is testing

Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients

Who this might be right for
Kidney TransplantationPediatric PatientsMaintenance With Tacrolimus
Seoul National University Hospital
Large-scale testing (Phase 3)Study completedNCT00239057
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,

Who this might be right for
Maintenance Renal Transplantation
Novartis 23
Large-scale testing (Phase 3)Study completedNCT00273871
What this trial is testing

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 190
Not applicableNo Longer AvailableNCT00149981
What this trial is testing

A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

Who this might be right for
Organ Transplantation
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00170846
What this trial is testing

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 394
Post-approval studies (Phase 4)Study completedNCT00129961
What this trial is testing

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Who this might be right for
Skin NeoplasmsKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 86
Large-scale testing (Phase 3)Study completedNCT00817206
What this trial is testing

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 326
Next Page